Arcadia Biosciences, Inc. (RKDA)
USD 5.87
(-0.51%)
USD 5.87
(-0.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.51 Million USD | 70.41% |
| 2022 | -18.62 Million USD | 26.64% |
| 2021 | -25.39 Million USD | -441.39% |
| 2020 | -4.69 Million USD | 24.09% |
| 2019 | -6.17 Million USD | 48.51% |
| 2018 | -11.99 Million USD | -31.48% |
| 2017 | -9.12 Million USD | -139.48% |
| 2016 | 23.11 Million USD | 2315.26% |
| 2015 | 957 Thousand USD | 145.66% |
| 2014 | -2.09 Million USD | -117.87% |
| 2013 | 11.72 Million USD | 342.6% |
| 2012 | 2.65 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -4.93 Million USD | -97.6% |
| 2024 Q1 | -2.49 Million USD | 54.73% |
| 2023 Q3 | -9.34 Million USD | 21.9% |
| 2023 Q2 | -11.95 Million USD | 43.65% |
| 2023 FY | -5.51 Million USD | 70.41% |
| 2023 Q4 | -5.51 Million USD | 41.0% |
| 2023 Q1 | -21.22 Million USD | -13.94% |
| 2022 Q3 | -20.46 Million USD | -9.2% |
| 2022 Q4 | -18.62 Million USD | 8.98% |
| 2022 FY | -18.62 Million USD | 26.64% |
| 2022 Q1 | -21.8 Million USD | 14.12% |
| 2022 Q2 | -18.74 Million USD | 14.06% |
| 2021 Q4 | -25.39 Million USD | 19.94% |
| 2021 Q3 | -31.71 Million USD | 12.05% |
| 2021 Q2 | -36.06 Million USD | -40.44% |
| 2021 Q1 | -25.67 Million USD | -447.51% |
| 2021 FY | -25.39 Million USD | -441.39% |
| 2020 Q1 | -6.97 Million USD | -12.88% |
| 2020 FY | -4.69 Million USD | 24.09% |
| 2020 Q4 | -4.69 Million USD | -595.85% |
| 2020 Q2 | -5.89 Million USD | 15.53% |
| 2020 Q3 | -674 Thousand USD | 88.56% |
| 2019 Q4 | -6.17 Million USD | 66.32% |
| 2019 FY | -6.17 Million USD | 48.51% |
| 2019 Q1 | -8.09 Million USD | 32.55% |
| 2019 Q2 | -12.44 Million USD | -53.75% |
| 2019 Q3 | -18.34 Million USD | -47.43% |
| 2018 FY | -11.99 Million USD | -31.48% |
| 2018 Q2 | -9.66 Million USD | 52.65% |
| 2018 Q1 | -20.41 Million USD | -123.76% |
| 2018 Q4 | -11.99 Million USD | -79.91% |
| 2018 Q3 | -6.66 Million USD | 31.01% |
| 2017 Q1 | 17.61 Million USD | -23.79% |
| 2017 Q2 | 11.78 Million USD | -33.09% |
| 2017 FY | -9.12 Million USD | -139.48% |
| 2017 Q3 | -2.93 Million USD | -124.86% |
| 2017 Q4 | -9.12 Million USD | -211.43% |
| 2016 Q1 | -4.56 Million USD | -576.7% |
| 2016 Q4 | 23.11 Million USD | 58.27% |
| 2016 Q3 | 14.6 Million USD | 725.98% |
| 2016 Q2 | -2.33 Million USD | 48.86% |
| 2016 FY | 23.11 Million USD | 2315.26% |
| 2015 Q4 | 957 Thousand USD | 102.4% |
| 2015 FY | 957 Thousand USD | 145.66% |
| 2015 Q3 | -39.86 Million USD | 30.3% |
| 2015 Q1 | 1.67 Million USD | 179.82% |
| 2015 Q2 | -57.19 Million USD | -3518.89% |
| 2014 Q3 | -6.62 Million USD | 41.94% |
| 2014 Q4 | -2.09 Million USD | 68.34% |
| 2014 Q2 | -11.4 Million USD | -502.22% |
| 2014 FY | -2.09 Million USD | -117.87% |
| 2014 Q1 | 2.83 Million USD | -75.83% |
| 2013 Q1 | 5.35 Million USD | 0.0% |
| 2013 Q4 | 11.72 Million USD | 0.0% |
| 2013 FY | 11.72 Million USD | 342.6% |
| 2012 FY | 2.65 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 215.18 Million USD | 102.561% |
| Muliang Viagoo Technology, Inc. | 1.08 Million USD | 605.75% |
| N2OFF, Inc. | -4.39 Million USD | -25.27% |
| Yield10 Bioscience, Inc. | 2.11 Million USD | 361.185% |